KPV Kategorie 4 Situation in Deutschland: Aufgrund der klaren pharmakologischen Wirkung als Funktionsarzneimittel eingestuft
As a therapeutic peptide, TB-500 promotes systemic healing accelerating recovery from muscle tears, reducing chronic inflammation that impairs training adaptation, improving flexibility and range of motion in damaged connective tissue, and supporting cardiac and smooth muscle repair
Yuen MF, Lim SG, Plesniak R, Tsuji K, Janssen HLA, Pojoga C, Gadano A, Popescu CP, Stepanova T, Asselah T, Diaconescu G, Yim HJ, Heo J, Janczewska E, Wong A, Idriz N, Imamura M, Rizzardini G, Takaguchi K, Andreone P, Arbune M, Hou J, Park SJ, Vata A, Cremer J, Elston R, Luki T, Quinn G, Maynard L, Kendrick S, Plein H, Campbell F, Paff M, Theodore D, B-Clear Study Group
If the rate of absorption is rapid relative to distribution (this is always true for rapid intravenous administration), the concentration of drug in plasma that results from an appropriate loading dosecalculated using the apparent volume of distributioncan initially be considerably higher than desired
TABLE 8